Zapatero A - Search Results

1

Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.

Kishan AU, Sun Y, Hartman H, Pisansky TM, Bolla M, Neven A, Steigler A, Denham JW, Feng FY, Zapatero A, Armstrong JG, Nabid A, Carrier N, Souhami L, Dunne MT, Efstathiou JA, Sandler HM, Guerrero A, Joseph D, Maingon P, de Reijke TM, Maldonado X, Ma TM, Romero T, Wang X, Rettig MB, Reiter RE, Zaorsky NG, Steinberg ML, Nickols NG, Jia AY, Garcia JA, Spratt DE; MARCAP Consortium group. Kishan AU, et al. Among authors: zapatero a. Lancet Oncol. 2022 Feb;23(2):304-316. doi: 10.1016/S1470-2045(21)00705-1. Epub 2022 Jan 17. Lancet Oncol. 2022. PMID: 35051385

2

Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: dose-volume effect.

Zapatero A, García-Vicente F, Modolell I, Alcántara P, Floriano A, Cruz-Conde A, Torres JJ, Pérez-Torrubia A. Zapatero A, et al. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1343-51. doi: 10.1016/j.ijrobp.2004.01.031. Int J Radiat Oncol Biol Phys. 2004. PMID: 15275719

3

Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study.

Zapatero A, Valcárcel F, Calvo FA, Algás R, Béjar A, Maldonado J, Villá S. Zapatero A, et al. J Clin Oncol. 2005 Sep 20;23(27):6561-8. doi: 10.1200/JCO.2005.09.662. J Clin Oncol. 2005. PMID: 16170164 Clinical Trial.

4

Dose escalation with three-dimensional conformal radiotherapy for prostate cancer. Is more dose really better in high-risk patients treated with androgen deprivation?

Zapatero A, Ríos P, Marín A, Mínguez R, García-Vicente F. Zapatero A, et al. Clin Oncol (R Coll Radiol). 2006 Oct;18(8):600-7. doi: 10.1016/j.clon.2006.06.010. Clin Oncol (R Coll Radiol). 2006. PMID: 17051950

5

Is hormone therapy a protective factor for late hematuria after high-dose radiotherapy in prostate cancer?

Zapatero A, García-Vicente F, Sevillano D, Martín de Vidales C, Ferrer C, Torres JJ, Minguez R, Rabadán M. Zapatero A, et al. Urology. 2008 Nov;72(5):1130-4. doi: 10.1016/j.urology.2008.01.057. Epub 2008 Apr 8. Urology. 2008. PMID: 18400265

6

Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy: what can they teach us?

Zapatero A, Mínguez R, Nieto S, Martín de Vidales C, García-Vicente F. Zapatero A, et al. Eur Urol. 2009 Apr;55(4):902-9. doi: 10.1016/j.eururo.2008.04.076. Epub 2008 May 7. Eur Urol. 2009. PMID: 18485578

7

Updated results of bladder-sparing trimodality approach for invasive bladder cancer.

Zapatero A, Martin de Vidales C, Arellano R, Bocardo G, Pérez M, Ríos P. Zapatero A, et al. Urol Oncol. 2010 Jul-Aug;28(4):368-74. doi: 10.1016/j.urolonc.2009.01.031. Epub 2009 Apr 11. Urol Oncol. 2010. PMID: 19362865

8

Long-term results after high-dose radiotherapy and adjuvant hormones in prostate cancer: how curable is high-risk disease?

Zapatero A, García-Vicente F, Martín de Vidales C, Cruz Conde A, Ibáñez Y, Fernández I, Rabadán M. Zapatero A, et al. Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1279-85. doi: 10.1016/j.ijrobp.2010.07.1975. Epub 2010 Oct 6. Int J Radiat Oncol Biol Phys. 2011. PMID: 20932659

9

Practice patterns in the management of prostate cancer in Spain: results from a national survey among radiation oncologists in 2009.

Zapatero A, López-Torrecilla J, Herruzo I, Calvo FA; SEOR URONCOR GICOR participating Investigators. Zapatero A, et al. Clin Transl Oncol. 2013 Mar;15(3):226-32. doi: 10.1007/s12094-012-0913-0. Epub 2012 Aug 2. Clin Transl Oncol. 2013. PMID: 22855195

10

Infrastructures, treatment modalities, and workload of radiation oncology departments in Spain with special attention to prostate cancer.

López Torrecilla J, Zapatero A, Herruzo I, Calvo FA, Cabeza MA, Palacios A, Guerrero A, Hervás A, Lara P, Ludeña Martínez B, Del Cerro Peñalver E, Nagore G, Sancho G, Mengual JL, Mira M, Mairiño A, Samper P, Pérez S, Castillo I, Martínez Cedrés JC, Ferrer E, Rodriguez S, Maldonado X, Gómez Caamaño A, Ferrer C; Grupo de Investigación GICOR-URONCOR-SEOR. López Torrecilla J, et al. Among authors: zapatero a. Clin Transl Oncol. 2014 May;16(5):447-54. doi: 10.1007/s12094-013-1121-2. Epub 2013 Oct 25. Clin Transl Oncol. 2014. PMID: 24682792

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters